Dr Reddys Laboratories (RDY) Cash from Investing Activities (2009)
Dr Reddys Laboratories (RDY) posted quarterly Cash from Investing Activities of -$48.0 million for Q4 2009, down 242.86% quarter-over-quarter from -$14.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Cash from Investing Activities (2009) Analysis & Trends
Dr Reddys Laboratories' Cash from Investing Activities history runs 1 years deep, the most recent figure standing at -$48.0 million for Q4 2009.
- In Q4 2009, Cash from Investing Activities changed N/A year-over-year to -$48.0 million; the TTM figure through Dec 2009 stood at -$69.5 million (changed N/A YoY), while the FY2026 annual figure was -$700.0 million, down 2.64% from the prior year.
- Cash from Investing Activities for Q4 2009 stood at -$48.0 million, down from -$14.0 million in the prior quarter.
- The five-year high for Cash from Investing Activities was -$12.0 million in Q2 2009, with the low at -$48.0 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | -2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | -48.00 Mn |
| Dec 31, 2009 | -48.00 Mn |
| Sep 30, 2009 | -14.00 Mn |
| Sep 30, 2009 | -14.00 Mn |
| Jun 30, 2009 | -12.00 Mn |
| Jun 30, 2009 | -12.00 Mn |